Nuzenio

Regenerative Technology Inc

Regenerative Technology Inc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Price to sales forward of Harvard Apparatus Regenerative Technology Inc. – OTC:HRGN - TradingViewTradingView · Sun, 09 Aug 2026 21:59:07 GMTHarvard Apparatus Regenerative Technology Inc. (OTC: HRGN) Stock Price, News & Analysis - KalkineKalkine · Thu, 06 Aug 2026 20:00:00 GMTCreative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 13:27:21 GMTHarvard Apparatus Regenerative Technology amends 8-K to reclassify CEO $300,000 bridge note disclosure under Item 1.01 - BitgetBitget · Mon, 03 Aug 2026 20:11:03 GMTCEO financing: Harvard Apparatus (OTCQB: HRGN) issues $400K bridge notes - Stock TitanStock Titan · Mon, 03 Aug 2026 19:12:57 GMTInsider Bridge Note funds Harvard Apparatus (OTCQB: HRGN) with $300,000 loan - Stock TitanStock Titan · Mon, 03 Aug 2026 19:08:10 GMTHarvard Apparatus Regenerative Technology enters USD 200,000 bridge loan with CEO Junli He - BitgetBitget · Mon, 03 Aug 2026 11:12:56 GMTRegenerative Medical Technology Group Inc. Revenue Breakdown – OTC:RMTG - TradingViewTradingView · Sat, 01 Aug 2026 02:47:56 GMT

Timeline

Sun, 09 Aug 2026 21:59:07 GMTPrice to sales forward of Harvard Apparatus Regenerative Technology Inc. – OTC:HRGN - TradingView
Thu, 06 Aug 2026 20:00:00 GMTHarvard Apparatus Regenerative Technology Inc. (OTC: HRGN) Stock Price, News & Analysis - Kalkine
Thu, 06 Aug 2026 13:27:21 GMTCreative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms - The Manila Times
Mon, 03 Aug 2026 20:11:03 GMTHarvard Apparatus Regenerative Technology amends 8-K to reclassify CEO $300,000 bridge note disclosure under Item 1.01 - Bitget
Mon, 03 Aug 2026 19:12:57 GMTCEO financing: Harvard Apparatus (OTCQB: HRGN) issues $400K bridge notes - Stock Titan
Mon, 03 Aug 2026 19:08:10 GMTInsider Bridge Note funds Harvard Apparatus (OTCQB: HRGN) with $300,000 loan - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Regenerative Technology Inc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.